BigPharma Paid $325 Million in "Royalties" to Fauci, NIH Researchers
The Regulators Captured by the Regulated...
“We need more regulation” we all too often hear politicians say. As if “regulators” are our better angels who will save the day.
The reality is that all too often the regulations become a grifting scheme where the taxpayers get ripped off or the regulators end up loyal to the companies they are supposed to be keeping in check.
For example, a lieutenant colonel at the pentagon is an airframe safety inspector assigned to a secret new stealth aircraft project. His job is to make sure said proposed aircraft for sale to the Air Force is safe and does what the aircraft company claims. The company producing the new stealth aircraft asks the lieutenant colonel. “Say, when you retire in a couple of years how would you like to come on board with us as a consultant for $1 million over 3 years?” Guess who the lieutenant colonel is looking out for now.
BigPharma is adept at capturing regulators using several techniques. There is a revolving door of those in powerful government positions going to work for the companies they regulated and then back into government.
83 HIGH PROFILE POLITICAL APPOINTEES NOW WORK FOR BIGPHARMA - LINK.
Researchers at the National Institute of Health (NIH) are employees of the United States Government. You pay for the research they generate so, as a matter of law, they cannot demand royalties for chemical processes, or DNA chains or other such research. The taxpayer owns those patents, not the individual researchers, but BigPharma pays the researchers, and their superiors, royalties anyway.
American, Russian and Chinese pharmaceutical firms paid NIH employees $325 million in royalties over the last ten years. Where do you think their loyalties lie? The government lies, coverups and various actions that have enriched BigPharma over the COVID pandemic begin to make more sense in this light.
Open The Books filed a freedom of information lawsuit to find out who received payments after Dr. Anthony Fauci and others have been less than forthcoming in answering questions about these payments during congressional testimony.
Open the Books:
Newly released NIH documents show conclusively that statements made during congressional hearings to U.S. Sen. Rand Paul (R-KY) and Rep. John Moolenaar (R-MI) by then-NIH leaders Anthony Fauci and Lawrence Tabak were misleading, if not outright false, regarding third-party royalties paid before, during, and after the pandemic.
Tabak, then-acting director of the National Institutes of Health, and Fauci, then-director of the National Institutes of Allergies and Infectious Diseases, both claimed before Congress that they could not release the names of the companies paying NIH third party royalties.
Last week, however, our OpenTheBooks lawsuit based on our Freedom of Information Act request caused NIH to release new documents.
The newly released documents reveal – for the first time – the names of companies that paid NIH scientists $325 million in third party royalties from 56,000 transactions between September 2009 and October 2020.
Our OpenTheBooks oversight reporting — which led to three congressional hearings during 2022 regarding NIH’s secret third party royalty payments — is available here for review.
Here are some key findings from the new disclosures:
In U.S. Senate hearings during 2022, Dr. Anthony Fauci refused to disclose the companies who licensed his “inventions” and paid his third-party royalties. Finally, now, we know the companies paying him. They are listed below.
In U.S. Senate hearings during 2022, Dr. Anthony Fauci refused to disclose the companies who licensed his “inventions” and paid his third-party royalties. Finally, now, we know the companies paying him. They are listed below.
Chinese government-owned pharmaceutical companies, controlled by the Chinese Communist Party (CCP), paid the National Institutes of Health (NIH) third-party royalties to license technologies developed on the U.S. taxpayer dime. One such company neighbors the Wuhan Institute of Virology, collaborates with the lab, and even paid a royalty to Douglas Lowy, a multiple term acting director at the National Cancer Institute, a sub-institute of NIH.
Russian animal vaccine maker – which was allegedly a front for a Soviet bio-weapons lab – licensed inventions and paid royalties to NIH for tech developed with taxpayer dollars.
Purdue Pharma – the makers of the highly addictive and frequently abused OxyContin (oxycodone) – licensed tech developed with public funds and paid royalties to NIH – even after the company pleaded guilty to federal crimes relating to opioids.
Long-serving former NIH director, Francis Collins, received third party royalties on his inventions from four companies that themselves received nearly $50 million in federal contracts and grants since 2008.
During the pandemic, the American people started to worry that Big Government was too close to Big Pharma. Now, because of our oversight investigation at OpenTheBooks.com, we know just how close they are: NIH spends billions on the industry and now we know the industry sends millions back to NIH and its scientists.
Last year, the National Institutes of Health – Fauci’s former employer – doled out more than $30 billion in government grants to roughly 56,000 recipients. That taxpayer largess buys plenty of friends and enormous influence across the entire U.S. healthcare complex – the scientific, research, drug, therapeutic, and healthcare industries.
In turn, $325 million in royalty payments flowed back in the other direction from private companies, research outfits, non-profits, and academia to NIH and its scientists.
These payments from third-party payers enriched the agency, its leadership, and 2,400 individual NIH scientists. It took our Freedom of Information Act request – ignored by NIH in September 2021 – and our federal lawsuit filed in November 2021 to finally force production of these payment records. The public interest law firm, Judicial Watch, represents us.
For the details revealed by Open the Books continue reading HERE.
UPDATE: Veteran Investigative Journalist Sharyl Attkisson interviews Asa, Andrzewski from OpenTheBooks HERE. “Getting the information was a knockdown, drag out dog fight” to get the information from NIH.
NTD News has a brief video report below:
UPDATE II - Sharyl Atkisson in a follow up interview with Adam Andrzewski on Rumble Video:
